bioRxiv Science⌕ Search

Biology subjects

Lesani, M.

Publications and source records attributed to Lesani, M..

3 recordsLinked to original sources

Spatially-divergent metabolic impact of experimental toxoplasmosis: immunological and microbial correlates

Maladaptive host metabolic responses to infection are emerging as major determinants of infectious disease pathogenesis. However, the factors regulating these metabolic changes within tissues remain poorly understood. In this study, we used toxoplasmosis, as a prototypical example of a disease regulated by strong type I immune responses, to assess the relative roles of local parasite burden, local tissue inflammation and the microbiome in shaping local tissue metabolism during acute and chronic infection. Toxoplasmosis is a zoonotic disease caused by the parasite Toxoplasma gondii. This protozoan infects the small intestine and then disseminates to nearly every organ in the acute stage of infection, before establishing chronic infection in the skeletal muscle, cardiac muscle and brain. We compared metabolism in eleven sampling sites in C57BL/6 mice during the acute and chronic stage of T. gondii infection. Strikingly, significant metabolic changes were observed in the large intestine and colon during chronic infection, organs not associated with T. gondii persistence. Overall, major spatial mismatches were observed between metabolic perturbation and local parasite burden for both disease stages. In contrast, a stronger association with indicators of type I immune responses was observed, indicating a tighter relationship between metabolic perturbation and local immunity, than with local parasite burden. In addition, we observed significant changes in microbiota composition with infection, and candidate microbial origins for multiple metabolites impacted by infection. These findings highlight the metabolic consequences of toxoplasmosis across different organs, and their regulators. ImportanceInflammation is a major driver of tissue perturbation. However, the signals driving these changes on a tissue-intrinsic and molecular level are poorly understood. This study evaluated tissue-specific metabolic perturbations across eleven sampling sites following systemic murine infection with the parasite Toxoplasma gondii. Results revealed relationships between differential metabolite enrichment and variables including inflammatory signals, pathogen burden and commensal microbial communities. These data will inform hypotheses about the signals driving specific metabolic adaptation in acute and chronic protozoan infection, with broader implications for infection and inflammation in general.

microbiology↗

Persistent biofluid small molecule alterations induced by Trypanosoma cruzi infection are not restored by antiparasitic treatment

Table of contents graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=105 SRC="FIGDIR/small/543565v1_figu1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@10c3a0aorg.highwire.dtl.DTLVardef@1b69d6dorg.highwire.dtl.DTLVardef@199867org.highwire.dtl.DTLVardef@64b20b_HPS_FORMAT_FIGEXP M_FIG C_FIG Chagas Disease (CD), caused by Trypanosoma cruzi (T. cruzi) protozoa, is a complicated parasitic illness with inadequate medical measures for diagnosing infection and monitoring treatment success. To address this gap, we analyzed changes in the metabolome of T. cruzi-infected mice via liquid chromatography tandem mass spectrometry analysis of clinically-accessible biofluids: saliva, urine, and plasma. Urine was the most indicative of infection status, across mouse and parasite genotypes. Metabolites perturbed by infection in the urine include kynurenate, acylcarnitines, and threonylcarbamoyladenosine. Based on these results, we sought to implement urine as a tool for assessment of CD treatment success. Strikingly, it was found that mice with parasite clearance following benznidazole antiparasitic treatment had comparable overall urine metabolome to mice that failed to clear parasites. These results match with clinical trial data in which benznidazole treatment did not improve patient outcomes in late-stage disease. Overall, this study provides insights into new small molecule-based CD diagnostic methods and a new approach to assess functional treatment response.

microbiology↗

Optimized extraction method enables quantitative analysis of surface metabolite recovery for exposomics and behavioral studies

Workplace chemical exposures are a major source of occupational injury. Although over half of these are skin exposures, exposomics research often focuses on chemical levels in the air or in worker biofluids such as blood and urine. Until now, one limitation has been the lack of methods to quantitatively measure surface chemical transfer. Outside the realm of harmful chemicals, the small molecules we leave behind on surfaces can also reveal important aspects of human behavior. In this study, we developed a swab-based quantitative approach to determine small molecule concentrations across common surfaces. We demonstrate its utility using one drug, cyclobenzaprine, and two human-derived metabolites, carnitine and phenylacetylglutamine, on four common surfaces: linoleum flooring, plastified laboratory workbench, metal and Plexiglass. This approach enabled linear small molecule recovery and quantification of molecule abundance on workplace built environment surfaces. Overall, this method paves the way for future quantitative exposomics studies.

biochemistry↗